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Abstract
Background: Acidification of the cytoplasm and the extracellular environment is associated with many physiological and
pathological conditions, such as intense exercise, hypoxia and tumourigenesis. Acidification affects important cellular
functions including protein synthesis, growth, and proliferation. Many of these vital functions are controlled by mTORC1, a
master regulator protein kinase that is activated by various growth-stimulating signals and inactivated by starvation
conditions. Whether mTORC1 can also respond to changes in extracellular or cytoplasmic pH and play a role in limiting
anabolic processes in acidic conditions is not known.
Methodology/Findings: We examined the effects of acidifying the extracellular medium from pH 7.4 to 6.4 on human
breast carcinoma MCF-7 cells and immortalized mouse embryo fibroblasts. Decreasing the extracellular pH caused
intracellular acidification and rapid, graded and reversible inhibition of mTORC1, assessed by measuring the
phosphorylation of the mTORC1 substrate S6K. Fibroblasts deleted of the tuberous sclerosis complex TSC2 gene, a major
negative regulator of mTORC1, were unable to inhibit mTORC1 in acidic extracellular conditions, showing that the TSC1–
TSC2 complex is required for this response. Examination of the major upstream pathways converging on the TSC1–TSC2
complex showed that Akt signaling was unaffected by pH but that the Raf/MEK/ERK pathway was inhibited. Inhibition of
MEK with drugs caused only modest mTORC1 inhibition, implying that other unidentified pathways also play major roles.
Conclusions: This study reveals a novel role for the TSC1/TSC2 complex and mTORC1 in sensing variations in ambient pH.
As a common feature of low tissue perfusion, low glucose availability and high energy expenditure, acidic pH may serve as a
signal for mTORC1 to downregulate energy-consuming anabolic processes such as protein synthesis as an adaptive
response to metabolically stressful conditions.
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Introduction
Acidification of the extracellular space or the cytoplasm is
observed in a number of physiological and pathological
conditions associated with intense energy expenditure, metabolic
disturbance or hypoperfusion. During high intensity exercise, the
intracellular pH of the skeletal muscle can transiently decrease
from a normal of 7.0 to as low as 6.2 due to high metabolic acid
production [1]. Elevated levels of acetoacetate and D-b-
hydroxybutyrate during starvation- or diabetes-induced ketogen-
esis can decrease the blood pH from a normal of 7.4 to 7.0–7.1
[2]. Hypoxia and ischemia in animal models induce major
intracellular and extracellular acidification, with decreases
reaching 0.8–1.2 pH units in the brain [3]. Cardiac arrest also
triggers intracellular acidification that rapidly reaches pH values
of 6.0–6.5 in the myocardium and the cerebral cortex and returns
to normal values within a few minutes upon resuscitation [4,5].
Low extracellular pH is a hallmark of solid tumours with values
as low as 6.2 [6,7,8] probably resulting from poor vascularization
and the heavy reliance of tumour cells on glycolysis for ATP
production [9,10].
Important cellular processes such as protein synthesis, growth
and proliferation are negatively impacted by even mild acidifica-
tion [11,12,13,14,15,16]. It is unclear whether this reflects an
adaptive cellular response to adverse conditions or merely an
inability of cells to function normally at suboptimal pH. The Ser/
Thr kinase mTOR is a master regulator of cell metabolism,
growth, survival and proliferation [17] that is active when
conditions are conducive for growth. mTOR is found in two
functionally and structurally distinct multiprotein complexes,
mTORC1 and mTORC2, which signal via distinct effector
pathways [18]. mTORC1 is negatively regulated by the TSC1–
TSC2 complex which integrates several major upstream
mTORC1 regulatory signals including growth factors, low energy
(ATP) and oxygen depletion [19,20]. This study examines the role
of the mTORC1 signaling pathway in the cellular response to
changes in pH. The results show that mTORC1 activity is rapidly
and reversibly inhibited by acidification through a TSC complex-
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21549dependent mechanism and identify pH as a further environmental
input into mTORC1 signaling.
Results
Reversible inhibition of mTORC1 signaling by
extracellular acidic pH
The extracellular pH of solid tumours is commonly acidic,
ranging from 6.2–7.0 [8] and blood pH can drop to below 7.0
during severe metabolic acidosis [2,21]. To examine whether
acidic extracellular pH in this range affects mTORC1 signaling,
human breast carcinoma MCF-7 cells were incubated for 5 min or
30 min in cell culture medium buffered to different pH values.
Phosphorylation of the mTORC1 substrates p70 S6K and p85
S6K was monitored with a phosphospecific antibody and by
examining the electrophoretic mobility of S6K, which is reduced
by phosphorylation. Exposure of cells to pH 6.2–6.6 elicited a
rapid and pronounced decrease in mTORC1 signaling that was
detectable within 5 min and essentially complete by 30 min
(Fig. 1A). Exposure to medium buffered to pH 6.8–7.0 caused
partial mTORC1 inhibition at 30 min while high mTORC1
activity was observed at physiological pH values of 7.2 and 7.4
(Fig. 1A).
If mTORC1 is a component of an adaptive response to pH
change, its inhibition by acidic pH should be reversible and its
activity should return to normal upon reestablishment of
physiological pH conditions. Cells were incubated in medium
buffered to pH 6.4 or 7.4 for 30 min, after which time the medium
was replaced with medium buffered to pH 7.4 and mTORC1
activity was examined at different times. After 30 min exposure to
pH 6.4, mTORC1 activity was strongly repressed while it
remained high at pH 7.4 (Fig. 1B, lanes 0). When cells were
transferred from pH 6.4 to pH 7.4, mTORC1 activity increased
detectably within 5 min and returned to normal values within
30 min (Fig. 1B). In the control experiment, transfer of cells from
pH 7.4 to pH 7.4 caused no change in mTORC1 activity, as
expected (Fig. 1B).
mTOR is also the catalytic subunit of mTORC2 that
phosphorylates PKB/Akt at Ser
473 [22,23,24]. Examination of
PKB/Akt Ser
473 phosphorylation in the same samples revealed
that exposure to acidic pH did not inhibit mTORC2 (Fig. 1A),
indicating that acidic extracellular pH does not directly inhibit the
catalytic activity of mTOR but probably impacts an upstream
mTORC1 regulatory signal. Therefore, acidic extracellular pH
values commonly found in solid tumours or during acidosis can
rapidly and reversibly inhibit mTORC1 signaling.
Effect of extracellular acidification on intracellular pH
Cells might respond by directly sensing extracellular pH and/or
via intracellular sensors if intracellular pH is affected by
extracellular acidification. We next monitored the effects of
varying extracellular pH on intracellular pH in cells transfected
with a novel fluorescent ratiometric reporter consisting of pH
insensitive mCherry fused to the de4GFP pH-sensitive variant of
GFP [25]. Calibration under pH-clamp conditions using the
protonophore nigericin (high K
+,1 0mM nigericin) showed that
intracellular acidification causes a red shift in fluorescence (Fig. 2A)
that is linear between pH 6.75 and 8.0 (Fig. 2B). MCF-7 cells
expressing mCherry/de4GFP were exposed to medium buffered
to pH 6.2, 6.4, 6.6 or 7.4 and changes in intracellular pH were
monitored over time. At normal external pH of 7.4, the
intracellular pH was slightly lower (7.35–7.40) for the 1 h
observation period (Fig. 2C). Extracellular acidification caused a
time-dependent decrease in intracellular pH. Within 5 min
exposure to extracellular pH of 6.2, 6.4 or 6.6, the internal pH
decreased to 7.0660.02, 7.1160.02 or 7.1760.02, respectively.
After 1 h, the internal pH had further dropped to 6.7760.01,
6.8860.01 and 7.0360.01 respectively (Fig. 2 C). Composite
images of the MCF-7 cells show the decrease in intracellular
green/red fluorescence ratio with decreased extracellular pH
(Fig. 2D). The observation that extracellular acidification causes
rapid changes in intracellular pH raises the possibility that signals
controlling mTORC1 might originate from inside the cell, while
not excluding an involvement of cell surface sensors.
mTORC1 inactivation by acidification requires TSC2
The TSC1–TSC2 complex plays a central role in control of
mTORC1 by integrating signaling from several upstream
pathways to negatively regulate mTORC1 [20]. Immortalized
mouse embryo fibroblasts (MEF) deleted of both TSC2 alleles
show high mTORC1 activity compared to their wild-type
counterparts (Fig. 3A), consistent with TSC2’s role as a negative
regulator of mTORC1 [20]. To determine whether a functional
TSC1–TSC2 pathway is required for negative regulation of
mTORC1 by acidic pH, TSC2
+/+ and TSC2
2/2 MEFs were
exposed for 1 h to medium at different pH values. Acidic
extracellular pH (6.2–6.6) completely inhibited mTORC1 in
TSC2
+/+ MEFs (Fig. 3A). By contrast, when TSC2
2/2 MEFs
were exposed to acidic pH, no decrease in mTORC1 activity was
detected, as seen from a lack of reduction in the phospho S6K
Thr
389 signal and a lack of change in the electrophoretic mobility
of S6K (Fig. 3A).
By comparison, the phosphorylation of PKB/Akt at its two
activating sites Ser
473 and Thr
308 by mTORC2 and PDK1,
respectively, was not strongly affected by acidic pH in TSC2
+/+ or
TSC2
2/2 cells (Fig. 3A). These results show that the TSC1–TSC2
complex is required for cells to inhibit mTORC1 when exposed to
acidic pH and may implicate it in relaying upstream pH-sensing
signals to mTORC1.
Inhibition of the Raf-MEK-ERK pathway by extracellular
acidic pH
The TSC1–TSC2 complex acts as a hub that integrates
different upstream signals to control mTORC1 activity [20].
Growth factor signaling to the TSC1–TSC2 complex takes place
in part via activation of the Ras-Raf-MEK-ERK signaling
cascade. Both ERK and the downstream kinase p90RSK can
phosphorylate TSC2 and inhibit the TSC1–TSC2 complex,
leading to activation of mTORC1 [26]. Exposure of TSC2
+/+
cells to acidic pH caused a profound inhibition of the
phosphorylation of ERK at its activation sites Thr
202/Tyr
204
(Fig. 3A). Cells lacking TSC2 showed a lower basal level of ERK
phosphorylation at physiological pH than cells expressing TSC2,
possibly as a consequence of aberrantly high mTORC1 activity
[27], and also a more modest reduction in ERK phosphorylation
at acidic pH. ERK is phosphorylated at Thr
202/Tyr
204 by MEK,
indicating that acidic extracellular pH inactivates MEK. MEK is
itself activated by phosphorylation at Ser
217/221 by Raf kinases.
Exposure to acidic extracellular pH also caused a strong reduction
in MEK Ser
217/221 phosphorylation in TSC2
+/+ cells (Fig. 3A).
TSC2
2/2 cells showed a lower basal level of MEK phosphory-
lation at physiological pH and a much smaller reduction in MEK
phosphorylation at acidic pH (Fig. 3A). Human breast carcinoma
MCF-7 cells exposed similarly to acidic medium showed
essentially complete inhibition of mTORC1 and decreased
phosphorylation of ERK1/2 at Thr
202/Tyr
204, MEK1/2 at
Ser
217/221, especially at pH 6.2 (Fig. 3B), whereas phosphorylation
of the mTORC2 substrate AKT was not affected (Fig. 3B).
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by which Raf is activated in response to growth factors are still
incompletely understood but involve phosphorylation at Ser
338 of
Raf-1, possibly by autophosphorylation [28]. Raf-1 Ser
338
phosphorylation was significantly reduced at acidic pH in
TSC2
+/+ cells (Fig. 3A) and MCF-7 cells (Fig. 3B). Similar to
ERK and MEK phosphorylation, Raf-1 Ser
338 phosphorylation
was lower in cells lacking TSC2 and its activity was not reduced by
acidic extracellular pH. Raf is inactive when cytosolic and
recruitment to the plasma membrane is required for activation
Figure 1. Rapid and reversible inhibition of mTORC1 signaling by acidic extracellular pH. A, MCF-7 cells were exposed for 5 min or
30 min to cell culture medium buffered to the indicated pH values. Lysates were analysed for mTORC1 activation by western blotting using
antibodies to phospho-Thr
389 S6K and to S6K and for mTORC2 activation using antibodies to phospho-Ser
473 PKB/Akt and to PKB/Akt. Tubulin
immunodetection was used as a protein loading control. B, MCF-7 cells grown in normal cell culture medium were exposed to medium buffered to
pH 6.4 or 7.4 for 30 min. The medium was removed and replaced with medium buffered to pH 7.4 and samples were harvested immediately (0 min)
or at the indicated times. In parallel, cells were exposed or not to the mTORC1 inhibitor rapamycin (Rapa, 30 nM) for 30 min in normal cell culture
medium (CM). Lysates were analysed by immunoblotting. Note that changing the cell culture medium caused a minor and transient decrease in PKB/
Akt Ser
473 phosphorylation that was independent of acidic pH. Results shown in all figures are representative of three or more independent
experiments.
doi:10.1371/journal.pone.0021549.g001
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rescence microscopy indicated that acidic extracellular pH did not
prevent membrane association of Raf-1 (not shown).
To determine the extent to which MEK-ERK inactivation
contributes to mTORC1 inhibition, MEK was inhibited using
drugs. In all three cell lines, PD98059 (50 mM) strongly inhibited
ERK-activating Thr
202/Tyr
204 phosphorylations (Fig. 4A) and
PD184352 (3 and 10 mM) caused complete inhibition (Fig. 4B).
Both inhibitors caused a modest reduction in mTORC1 activity in
TSC2
+/+ cells, seen by decreased phospho-S6K antibody
reactivity and increased S6K electrophoretic mobility (Fig. 4). In
TSC2
2/2 and MCF-7 cells, PD98059 and PD184352 caused little
or no decrease in mTORC1 signaling despite efficiently inhibiting
ERK phosphorylation (Fig. 4). Together, these data indicate that
in TSC2
+/+ cells that display normal levels of mTORC1 signaling,
acidic extracellular pH effectively inactivates the Raf-MEK-ERK
pathway but inhibition of the Raf-MEK-ERK pathway contrib-
utes only modestly to inhibition of mTORC1 signaling. The
results also indicate that in TSC2
2/2 MEFs and MCF-7 cells
displaying abnormal mTORC1 regulation, inactivation of MEK-
ERK does not significantly contribute to mTORC1 inhibition by
acidic pH.
Effect of acidic extracellular pH on other mTORC1control
pathways
Growth factors also signal to the TSC1–TSC2 complex via the
PI3K/Akt pathway.
Binding of growth factors to cell surface receptors results in
recruitment of PI3K to the membrane. The resulting generation of
PtdIns(3,4,5)P3 recruits Akt to the plasma membrane where it is
activated via phosphorylation at Thr
308 by PDK1 and at Ser
473 by
mTORC2. Akt then directly phosphorylates TSC2 to inactivate
the TSC1–TSC2 complex [20]. Exposure to acidic pH did not
affect Akt phosphorylation at either Thr
308 or Ser
473 in TSC2
2/2
and TSC2
+/+ MEFs (Fig. 3A) or MCF-7 cells (Fig. 1A, 3B),
indicating that the PI3K-Akt pathway does not participate in pH
sensing.
AMPK is a low-energy sensor; in response to ATP depletion it is
activated by phosphorylation at Thr
172 and inhibits mTOR-
dependent signaling by phosphorylating TSC2 [31,32,33]. Phos-
phorylation at Thr
172 was not stimulated by acidic extracellular
pH. AMPK Thr
172 phosphorylation actually decreased at acidic
pH in both TSC2
+/+ and TSC2
2/2 cells (Fig. 3A). Transcrip-
tional induction of REDD1, regulated by the HIF-1a transcription
factor, activates TSC2 to negatively regulate mTORC1 in
response to hypoxia [34,35]. This response requires de novo
transcription of the Redd1 gene [35]. Since we observed effects of
acidic extracellular pH on mTORC1 signaling within 5 minutes,
it is highly unlikely that pH affects TSC1–TSC2 through increased
transcription of REDD1, a response that takes over 3 hours
[35,36].
Starvation, which inhibits mTORC1, has recently been shown
to alter the localization of lysosomes within the cytoplasm and the
association of mTOR with lysosomes [37,38,39]. To determine
Figure 2. Changes in intracellular pH in cells exposed to extracellular acidification. A, Confocal images of CHO cells transfected with
mCherry/de4GFP under pH clamp (high [K
+]/Nigericin) from pH 6.75 to pH 8.0. An increase in green fluorescence indicates a pH shift in the alkaline
direction. Scale bar=10 mm. B, The relationship between mCherry/de4GFP fluorescence ratio and pH was determined. C, Intracellular pH in mCherry/
de4GFP transfected MCF-7 cells was monitored with time after the addition of cell culture medium buffered to the indicated pH values. N.70 cells
per condition. D, Sample images of MCF-7 cells exposed to control medium for 5 or 60 min or acidified media for 60 min are shown. A red shift
resulting from a loss of green fluorescence indicates intracellular acidification. Scale bar=10 mm.
doi:10.1371/journal.pone.0021549.g002
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were exposed to pH 6.4 or 7.4 for 1 h and mTOR and the
lysosomal marker LAMP1were visualized by immunofluorescence
microscopy. Exposure to pH 6.4 did not affect the cytoplasmic
distribution of lysosomes or the extent of co-localization of mTOR
with LAMP-1, which was similar in cells maintained in complete
culture medium or exposed to medium buffered to pH 7.4 or 6.4
(Fig. 5). By contrast, when cells were starved of amino acids and
serum, extensive delocalization of mTOR from LAMP-1 took
place (Fig. 5), as previously reported [38,39].
Effect of acidic extracellular pH on mTORC1 activation by
serum
The experiments described thus far were carried out in the
presence of serum, which contains growth factors that maintain
high mTORC1 activity, and show that exposure to acidic
extracellular pH can rapidly interrupt growth factor signaling.
We next wished to examine whether acidic pH would prevent the
activation of these pathways during stimulation by serum.
Serum starvation resulted in complete repression of mTORC1
activity in TSC2
+/+ MEFs as measured by S6K phosphorylation,
whilemTORC1was not inhibitedbyserum starvation inTSC2
2/2
MEFs (Fig. 6), as previously reported [40,41]. In the absence of
serum, phosphorylation of ERK at Thr
202/Tyr
204 and MEK at
Ser
217/221 was essentially absent and phosphorylation of Raf-1 at
Ser
338 was reduced in both TSC2
+/+ and TSC2
2/2 cells (Fig. 6). In
TSC2
+/+ cells, addition of serum at pH 7.4 strongly activated Raf,
MEK,ERKandmTORC1,asexpected (Fig.6).Bycontrast,serum
showed a reduced ability to activate these kinases in acidic
extracellular conditions (Fig. 6). In TSC2
2/2 cells, addition of
serum at pH 7.4 increased Raf, MEK and ERK phosphorylation
but curiously, addition of serum at acidic pH caused a transient
Figure 3. Effect of extracellular acidification on mTORC1 control pathways. TSC2
+/+ and TSC2
2/2 MEFs (A) or MCF-7 cells (B) were exposed
for 1 h to medium buffered to the indicated pH values or to 30 nM rapamycin for 1 h and lysates were analysed by western blotting using the
indicated antibodies.
doi:10.1371/journal.pone.0021549.g003
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than at physiological pH (Fig. 6).
In MCF-7 cells, serum withdrawal inhibited mTORC1
incompletely and serum was less able to stimulate mTORC1 at
acidic pH than at physiological pH (Fig. 7). Phosphorylation of
Raf, MEK and ERK was also considerably reduced by serum
starvation and addition of serum was also less efficient at
stimulating these kinases at acidic pH than physiological pH.
Therefore, acidic external pH both inhibits active mTORC1 and
curtails its activation by serum in the two cell lines.
Involvement of TSC2 in downregulation of protein
synthesis in response to acidification
Cellular acidification can negatively impact protein synthesis
[42]. To investigate the dependence of this effect on the TSC1–
TSC2 complex, TSC2
+/+ and TSC2
2/2 MEFs were exposed to
complete medium at pH 6.2, 6.4, 6.6 or 7.4 for 1 h and protein
synthesis was measured during the last 15 min of incubation.
Protein synthesis was strongly reduced at pH 6.2 in both cell lines
(Fig. 8). At pH 6.4 and 6.6, protein synthesis was only slightly
more inhibited in TSC2
+/+ MEFs than in TSC2
2/2 MEFs.
Figure 4. Effect of MEK inhibitors on mTORC1 signaling. Cells were exposed to the MEK inhibitors PD98059 or PD184352 or to rapamycin for
1 h in normal cell culture medium and lysates were analysed by western blotting using the indicated antibodies.
doi:10.1371/journal.pone.0021549.g004
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mTORC1 signaling is regulated by a number of extracellular
and intracellular cues including growth factors, nutrients, energy
and oxygen levels [43,44,45,46]. The main finding of this study is
that mTORC1 signaling is additionally controlled by acidic pH.
mTORC1 activity is inhibited rapidly, reversibly and in a graded
fashion by acidic extracellular pH within the range observed in a
variety of physiological or pathological conditions.
To shed light on the mechanisms involved in sensing and
relaying pH information to mTORC1, we examined the effect of
acidic extracellular pH on intracellular pH and on the major
signaling pathways known to control mTORC1 [43,47]. Exposure
of cells to acidic medium caused rapid acidification of the
cytoplasm. The rapid time course of both mTORC1 inhibition
and intracellular acidification is compatible with pH sensing taking
place inside the cell rather than exclusively from the cell surface.
Extracellular acidification failed to inhibit mTORC1 in cells
lacking TSC2, showing that activity of the TSC1–TSC2 complex
is required for mTORC1 inhibition and possibly implicating the
TSC1–TSC2 complex as a component of a pH sensing and signal
transduction pathway.
A number of mTORC1 regulatory pathways are known to
signal via the TSC1–TSC2 complex [43] and were examined in
this study. Extracellular acidification did not affect Akt phosphor-
ylation at either Thr
308 or Ser
473 in MEFs or MCF-7 cells,
suggesting that signaling through Pdk1 and mTORC2 is not
affected by pH. AMPK, which activates the TSC1–TSC2
complex, was not activated by acidic pH, indicating that
mTORC1 inhibition was also not a consequence of ATP
depletion. The rapid time course of mTORC1 inhibition by
acidic pH, which occurs within minutes, also argued against an
involvement of REDD1, which operates via changes in gene
expression, and consequently on a much longer time scale.
The Raf-MEK-ERK pathway was the only mTORC1 control
pathway signaling via the TSC1–TSC2 complex that was strongly
inhibited by acidic pH, particularly in TSC2
+/+ MEFs. This
pathway can inactivate the TSC1–TSC2 complex through direct
phosphorylation of TSC2 by ERK and Rsk [26,48] (Fig. S1).
Acidic pH inhibited activating phosphorylations of ERK and
MEK. In addition, acidification reduced the phosphorylation of C-
Raf at Ser
338in MEFs, which is required for maximal activity. The
identity of the kinase responsible for phosphorylating Raf is
uncertain but may be Raf itself [28,49], raising the possibility that
acidic pH affects Raf-1 dimerization or oligomerization. Phos-
phatidic acid plays an important role in activation of the ERK
cascade. The recruitment of Raf-1 to the membrane and its
activation require binding to phosphatidic acid [50,51]. The
charge of phosphatidic acid is affected by pH and phosphatidic
acid has been proposed as an intracellular cellular pH sensor [52].
However, extracellular acidification did not appear to prevent the
association of Raf with membranes, indicating that inhibition of
Raf-MEK-ERK signaling is not likely to be caused by an inability
of phosphatidic acid to bind Raf when cells are exposed to acidic
extracellular conditions. Importantly, complete inhibition of
MEK-ERK by drugs inhibited mTORC1 only modestly in
Figure 5. Effect of extracellular acidification on the cytoplasmic localization of mTOR and lysosomes. MCF-7 cells were left untreated,
exposed to medium buffered to pH 6.4 or 7.4 for 1 h, or exposed to HBSS for 2 h and immunostained using antibodies as shown. Yellow signal
indicates co-localization of mTOR and LAMP-1. Bar, 10 mm.
doi:10.1371/journal.pone.0021549.g005
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+/+ MEFs and not at all in TSC2
2/2 MEFs and MCF-7
cells, indicating that although Raf-MEK-ERK signaling is
sensitive to acidic pH, it is not the most important pathway
controlling mTORC1 activity by acidification. The identity of the
primary pH sensor responsible for controlling mTORC1 remains
to be identified.
Acidification of the cytoplasm, the extracellular space and the
blood is strongly associated with low tissue perfusion, low glucose
availability and high energy expenditure [53,54,55]. The obser-
vation that acidic pH controls mTORC1 by a mechanism
requiring the TSC1–TSC2 complex has interesting implications
for understanding the response and adaptation of cells to acidic
pH. Sensing of acidic pH may enable cells to rapidly reduce
mTORC1 activity to temporarily restrain energy-consuming
anabolic processes in response to a variety of metabolically
stressful conditions.
Figure 6. Effect of acidic extracellular pH on serum-induced activation of the mTORC1 pathway in TSC2
+/+ and TSC2
2/2 MEFs. Cells
were incubated in serum-free medium for 18 h and then exposed for 1 h to serum-containing medium buffered to the indicated pH or to 30 nM
rapamycin for 1 h. Lysates were analysed by western blotting using the indicated antibodies.
doi:10.1371/journal.pone.0021549.g006
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Chemicals and antibodies
General laboratory chemicals were purchased from Sigma-
Aldrich, Fisher Scientific and BDH, Inc. Rapamycin and
PD98059 were from Calbiochem, PD184352 from LC Labora-
tories, Hoechst 33342 from Invitrogen, and propidium iodide
from Sigma-Aldrich. Antibodies were from the following vendors:
Cell Signaling Technology, phospho Thr
389 S6K (#9205),
phospho Ser
473 PKB/Akt (#9271), PKB/Akt (#9272), phospho
Ser
380 p90RSK (#9341), phospho Ser
217/221 MEK1/2 (#9121),
phospho Thr
308 PKB/Akt (#9275), phospho Ser
259 Raf-1
(#9421), phospho-p44/42 Thr
202/204 MAPK (Erk1/2) (#9106),
AMPK (#2603), phospho Thr
172 AMPK (#2535), mTOR
(#2972); Santa Cruz Biotechnology, Inc., S6K C-18 (#230),
phospho Erk (#9106), Raf-1 E-10 (sc-7267), b-tubulin H-235
(#9104), Erk; Millipore, phospho Ser
338 Raf-1(05-538); Upstate,
4G10 phosphotyrosine (Tyr(P)); Developmental Studies Hybrid-
oma Bank, LAMP1 (H4A3); Invitrogen, Alexa fluor 488 goat-a-
rabbit (#A11008) and Alexa fluor 568 goat-a-mouse (#A11004).
Cell culture
MCF-7 cells [56] were maintained in RPMI-1640 medium
(GIBCO, #31800-022) supplemented with 0.2% sodium bicar-
bonate, 10% (v/v) fetal bovine serum and 100 units/ml penicillin/
streptomycin at 37uC in a 5% (v/v) CO2 humidified incubator.
TSC22/2/p532/2 and TSC2+/+/p532/2 MEFs were a
generous gift of Dr. David Kwiatkowski [40] and were maintained
in high glucose Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% (v/v) fetal bovine serum, 100 units/ml
penicillin/streptomycin and 2 mM L-glutamine (Sigma-Aldrich).
Treatment with acidic media
RPMI-1640 medium without sodium bicarbonate, containing
20 mM 3-(N-morpholino)propanesulfonic acid (MOPS), 10% (v/
v) fetal bovine serum and 50 units/ml penicillin/streptomycin was
pre-equilibrated for 30 min in a 5% (v/v) CO2 humidified
incubator at 37uC and adjusted to different pH values using HCl
or NaOH. All experiments were carried out with freshly prepared
media. Cells were seeded in 6-well plates at 1 million cells/well
(MCF-7), 400,000 cells/well (TSC2+/+) or 200,000 cells/well
(TSC2+/+) in normal culture medium and cultured overnight.
The next day, the medium was replaced with medium buffered to
the indicated pH values that had been pre-equilibrated in a 5% (v/
v) CO2 humidified incubator at 37uC and cells were incubated for
1 h. For starvation experiments, cells were rinsed with serum-free
medium and incubated overnight (,18 h) in serum-free medium.
The starved cells were treated with cell media buffered to various
pH values for 1 h as above.
Figure 7. Effect of acidic extracellular pH on serum-induced
activation of the mTORC1 pathway in MCF-7 cells. Cells were
incubated in serum-free medium for 18 h and then exposed for 1 h to
serum-containing medium buffered to the indicated pH or to 30 nM
rapamycin for 1 h. Lysates were analysed by western blotting using the
indicated antibodies.
doi:10.1371/journal.pone.0021549.g007
Figure 8. Effect of extracellular acidification on protein
synthesis. The incorporation of
35S-Met into protein was measured
in TSC2
+/+ and TSC2
2/2 MEFs exposed to cell culture medium buffered
to the indicated pH values. The rates of
35S-Met incorporation were
measured in the last 15 minutes of treatment to give cpm/mgo f
protein/15-min incubation. Results are expressed relative to the average
incorporation in pH 7.4 medium. (mean 6 S.D., n=6).
doi:10.1371/journal.pone.0021549.g008
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At the end of the experiment, the cells were rinsed with serum-
free ice-cold medium adjusted to the appropriate pH and were
immediately lysed by scraping in cold 20 mM Tris-HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% (v/v) Triton
X100, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate
supplemented with fresh 1 mM Na3VO4, 1 mM dithiothreitol and
16 complete protease inhibitor cocktail (Roche Molecular Bio-
chemicals) on ice. Lysates were pre-cleared by centrifugation at
18,000 g for 15 min at 4oC. SDS PAGE and immunoblotting were
carried outas described [56].The samples were separatedona 10%
acrylamide gel containing 0.33% methylene bisacrylamide except
for S6K phospho and S6K which were analyzed as described [56].
Protein synthesis
TSC2
+/+ and TSC2
2/2 MEFs in 24-well plates at 100,000
cells/well and 50,000 cells/well respectively in normal culture
medium and cultured overnight. The next day, the medium was
replaced with medium lacking methionine and supplemented with
dialysed fetal bovine serum buffered to the indicated pH values
that had been pre-equilibrated in a 5% (v/v) CO2 humidified
incubator at 37uC. After 45 min incubation, 5 mCi
35S-Met
(Perkin Elmer #NEG709A001MC) was added for an additional
15 min.
35S-Met incorporation was measured as described [57].
Intracellular pH measurement
The cDNA encoding mCherry was obtained from AddGene
(Cambridge, MA). HindIII and BamHI sites were introduced at
the 59 and 39 ends respectively of the mCherry coding region of
mCherry by PCR, and ligated into the corresponding sites of the
pde4GFP-N1 vector in frame with de4GFP [25]. MCF-7 cells,
grown on glass-bottom dishes (MatTek, Ashland, MA), were
transfected with mCherry/de4GFP fusion plasmid. The pH-
sensitive de4GFP and pH-insensitive mCherry fluorescence was
captured using an Olympus Fluoview confocal microscope by
excitation with a 488 nm laser or 543 nm laser respectively. To
calibrate mCherry/de4GFP fluorescence ratio to pH, Chinese
Hamster Ovary (CHO) cells were transfected with mCherry/
de4GFP and imaged by confocal microscopy under pH-clamp
conditions using the high-[K
+]/nigericin technique [58,59]. In the
calibration experiments, the fluorescence intensity of de4GFP
displayed a sigmoidal relationship to pH between pH 5.0 and
pH 9.0, and pKa was calculated to be 7.45, similar to the
previously reported value. Between pH 6.75 and 8.0, the
relationship between pH and mCherry/de4GFP fluorescence
ratio was linear [25]. MCF-7 cells expressing mCherry/de4GFP
were exposed to serum-containing media buffered to pH 7.4, 6.6,
6.4, or 6.2 and intracellular pH was monitored with time by
measuring the mCherry/de4GFP fluorescence ratio. Experimen-
tally measured ratios for each cell were converted to pH using the
linear relationship between fluorescence ratio and pH determined
in the calibration experiments.
Immunofluorescence microscopy
Cells were seeded on 76detergent-treated coverslips in 12-well
plates at 300,000 cells/well (MCF-7), 130,000 cells/well (TSC2
+/+)
or 60,000 cells/well (TSC2
2/2) in normal culture medium and
cultured overnight. The nextday, the cells were incubated for 1 h in
normalculturemediumormediumbufferedtopH 6.4orpH 7.4or
for 2 h in HBSS (Hanks Balanced Salt Solution, #37150, StemCell
Technologies). At the end of the incubation period the cells were
fixed in 3% paraformaldehyde for 15 min, permeabilized with
0.3% triton X-100 in PBS for 15 min, and blocked in 3% BSA in
PBS for 30 min. The cells were incubated with antibodies to
mTOR and LAMP-1 for 1 h and washed 3 times with 3% BSA in
PBS. The cells were then incubated with secondary antibodies for
45 min and further washed twice with 3% BSA in PBS. DNA was
stained with Hoechst 33342 (500 ng/ml) for 2 min, the cells were
washed 3 times with distilled water and the cover slips were
mounted on glass slides using Celvol. The cells were imaged using
confocal microscopy.
Supporting Information
Figure S1 Summary diagram of the major pathways
controlling mTORC1 via the TSC1–TSC2 complex and of
the kinase phosphorylation sites examined in this study.
Binding of growth factors to receptor tyrosine kinases (RTK)
activates the AKT and Ras/Raf/MEK/ERK pathways that
phosphorylate TSC2 at multiple sites and inhibit the formation of
TSC1–TSC2 complexes, thus de-repressing mTORC1 via Rheb-
GTP. Exposure to acidic extracellular pH inhibits mTORC1 (S6K
Thr
389phosphorylation), ERK Thr
202/Tyr
204 phosphorylation,
MEK Ser
217/221 phosphorylation and Raf Ser
338 phosphorylation.
Larger red asterisks indicate stronger phosphorylation inhibition.
(TIF)
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